Outset Medical Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Outset Medical Inc.
- Former names
- Home Dialysis Plus, Ltd.
- Ownership
- Public
- Status
- Active
- SIC code
- 3845 — Electromedical & Electrotherapeutic Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Jose
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- OM
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001484612
- EIN
- 20-0514392
Board of directors
-
Andrea Lynn Saia · DirectorSince 2023
-
Brent D. Lang · DirectorSince 2024
-
Catherine M. Szyman · DirectorSince 2023
-
D. Keith Grossman · DirectorSince 2023
-
Dale E. Jones · DirectorSince 2023
-
James F. Hinrichs · DirectorSince 2023
-
Karen Drexler · DirectorSince 2023
-
Karen Prange · DirectorSince 2026
-
Kevin C. Oboyle · DirectorSince 2025
-
Leslie Trigg · Director · Chair and CEOSince 2023
-
Patrick T. Hackett · DirectorSince 2023
Chief executives
Leslie Trigg
· Chair and CEO
Dates unknown
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
75.4%
-
96.0%
Board connections
8 of this board's directors also sit on 13 other boards.
- via Leslie Trigg
- via Andrea Lynn Saia
- via Karen Prange
- via Kevin C. Oboyle
- via Karen Prange
- via James F. Hinrichs
- via Andrea Lynn Saia
- via D. Keith Grossman
- via James F. Hinrichs
- via Karen Drexler
- via Dale E. Jones
- via Karen Drexler
- via Kevin C. Oboyle
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $369,187
- 23 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Brottem John L. Officer (General Counsel) | Open-market sale | −2,632 | $4.39 | $11,554 |
| Aug 17, 2026 | Renee Gaeta Officer (Chief Financial Officer) | Open-market sale | −4,543 | $4.39 | $19,944 |
| Aug 17, 2026 | Leslie Trigg Director, Officer (Chair and CEO) | Open-market sale | −3,437 | $4.39 | $15,088 |
| Jun 26, 2026 | Brottem John L. Officer (General Counsel) | Grant or award | +59,830 | — | — |
| Jun 26, 2026 | Renee Gaeta Officer (Chief Financial Officer) | Grant or award | +71,630 | — | — |
| Jun 26, 2026 | Leslie Trigg Director, Officer (Chair and CEO) | Grant or award | +99,160 | — | — |
| Jun 4, 2026 | Patrick T. Hackett Director | Grant or award | +10,667 | — | — |
| Jun 4, 2026 | Kevin C. Oboyle Director | Grant or award | +10,667 | — | — |
| Jun 4, 2026 | Karen Prange Director | Grant or award | +10,667 | — | — |
| Jun 4, 2026 | Brent D. Lang Director | Grant or award | +10,667 | — | — |
| Jun 4, 2026 | D. Keith Grossman Director | Grant or award | +10,667 | — | — |
| Jun 4, 2026 | Karen Drexler Director | Grant or award | +10,667 | — | — |
| Jun 3, 2026 | Renee Gaeta Officer (Chief Financial Officer) | Open-market sale | −17,672 | $4.94 | $87,300 |
| May 15, 2026 | Leslie Trigg Director, Officer (Chair and CEO) | Open-market sale | −3,445 | $3.70 | $12,747 |
| May 15, 2026 | Nash Marc Officer (EVP Operations R&D & Service) | Open-market sale | −1,582 | $3.70 | $5,853 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.